Family Medicine Doctors in Northborough, MA Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Dr. Kenneth Stillman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 112 Main St, Northborough, MA 01532 Phone: 508-351-9250

Apeksha Tripathi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 Main St, Suite 110, Northborough, MA 01532 Phone: 508-393-0131

Linda Asamoah Boateng, NP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10002a Shops Way, Northborough, MA 01532 Phone: 774-500-7334

Dr. Michael A Reyes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Sw Cutoff, Northborough, MA 01532 Phone: 774-570-5000    Fax: 774-570-5070

Mikhail Novikov, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 318 Main St Ste 165, Northborough, MA 01532 Phone: 508-936-1657

Dr. Todd Christopher Malvey, D.O. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 E Main St, Suite 208, Northborough, MA 01532 Phone: 508-393-0183    Fax: 508-393-2310

News Archive

Lannett Company plans to submit NDA for Morphine Sulfate products to FDA

Lannett Company, Inc. today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month.

AACN invites clinicians and researchers to apply for research grants

The American Association of Critical-Care Nurses (AACN) invites clinicians and researchers to apply for its grants, with awards ranging from $1,500 to $50,000.

First FOSAMAX case declared as mistrial by the U.S.District Court Judge

Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck, the first FOSAMAX case to go to trial. This case was the Plaintiffs' Steering Committee's first choice to take to trial. The Boles case was tried in New York federal court and involved a Florida woman who blamed her dental and jaw problems on FOSAMAX.

Ascenta, LLS enter agreement to develop AT-406 IAP small molecule inhibitor for acute myeloid leukemia

Ascenta Therapeutics, Inc. and The Leukemia & Lymphoma Society (LLS) today entered into an agreement whereby the LLS will support clinical development of Ascenta's oral small molecule inhibitor of IAPs (inhibitor of apoptosis proteins), AT-406, for patients with acute myeloid leukemia (AML).

Read more Medical News

› Verified 7 days ago